Search company, investor...

Executives

8

Board of Directors

6

AcuFocus Management Team

8 Team Members

AcuFocus has 8 executives. AcuFocus's former Chief Executive Officer is James V. Mazzo.

Name

Work History

Title

Status

James V. Mazzo

Chief Executive Officer

Former

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

James V. Mazzo

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Chief Executive Officer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Former

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

AcuFocus Board of Directors

6 Board of directors

AcuFocus has 6 board of directors, including Charles Warden.

Name

Firm

Work History

Other Seats

Charles Warden

Charles Warden is a Managing Director who has been a medical device venture investor since 1992. He works closely with entrepreneurial device companies every step of the way, from inception to success. Prior to joining Versant he was a general partner at Schroder Ventures Life Sciences (now SV Life Sciences) where he led the SV medical device effort. Previously, Charles worked with Boston Capital Ventures, where he concentrated on medical device and other healthcare investments. Before becoming a venture capitalist, Charles was a consultant with Monitor Company, a strategy consulting firm. Charles has been actively involved with The Innovation Factory, a medical devices incubator, since its beginnings in 1999. He is also involved in ForSight Labs, an ophthalmic incubator, and with The Foundry, a medical devices incubator.

AcuFocus

Gregory Madden

AcuFocus

James Garvey

AcuFocus

Juliet Bakker

Ms. Bakker is a Managing Director and Founder of Longitude Capital. Prior to Longitude Capital, Ms. Bakker was a Managing Director of Pequot Ventures, where she founded the life sciences investment practice. Prior to Pequot, she was Director, Strategic Planning and Director, Operations of Waste Management International, and was a sell-side equity analyst with Banque Paribas. Ms. Bakker began her career as an investment banker in the corporate finance department at PaineWebber. She currently serves on the boards of Ceribell, Endogenex, Nalu, and RxSight (RXST). Selected prior board memberships include Ablation Frontiers (acquired by Medtronic), Alphaeon, AqueSys (acquired by Allergan), Axonics Modulation Technologies (AXNX), CryoVascular Systems (acquired by Boston Scientific), Eargo (EAR), Embolic Protection (acquired by Boston Scientific), Enteric Medical (acquired by Boston Scientific), eyeonics (acquired by Bausch+Lomb), Genyx Medical (acquired by C.R. Bard), Insulet (PODD), Precision Dermatology (acquired by Valeant Pharmaceuticals), Sadra Medical (acquired by Boston Scientific), and Venus Concept (VERO). Ms. Bakker holds an MPA from the Harvard Kennedy School and a BSc from the College of Agriculture and Life Sciences (”CALS”) at Cornell University, where she is a member of the CALS Advisory Council.

AcuFocus

Ryan Schwarz

Mr. Schwarz has nearly 20 years of investment and financing experience in healthcare. Prior to co-founding NaviMed Capital, Mr. Schwarz led the US healthcare venture and growth capital practice at The Carlyle Group for 14 years. His team’s investing activities focused particularly on medical devices and products, healthcare information technology and selected healthcare services. He joined The Carlyle Group in 1997 at the inception of its $210 million initial US venture capital fund, and led the healthcare investing practice from that time through the venture group’s second fund, which closed on $602 million in 2001 targeting venture and growth capital investments, and third fund, which closed on $605 million in 2006 targeting growth capital investments and growth-oriented leveraged buyouts. Mr. Schwarz previously was a Vice President in the healthcare group at Robertson Stephens, where he led the firm’s healthcare IT investment banking efforts and also served clients in the medical device and healthcare services sectors. Earlier in his career, Mr. Schwarz was an investment banker at Morgan Stanley. Mr. Schwarz is currently a member of the Board of Directors of AcuFocus, AqueSys, NeoVista, and Proteus Digital Health. He was formerly a Director of numerous prior portfolio companies of The Carlyle Group, including Carefx (sold to Harris), ConnectiCare (sold to Emblem Health), Endius (sold to Zimmer), Fairchild Imaging (sold to BAE Systems), LipoSonix (sold to Medicis Pharmaceuticals) and Heritage Health Systems (sold to Universal American). Mr. Schwarz currently serves on the Board of George Mason Intellectual Properties (GMIP) which manages the commercialization of the university’s patents. He also serves as President of the Hungarian-American Enterprise Scholarship Fund, which provides fellowships to promising young Hungarian nationals to obtain private sector professional experience in the United States. From 2006 to 2011, Mr. Schwarz served on the Board of the Mid-Atlantic Venture Association, the industry association for venture capital and private equity firms in the Mid-Atlantic region. Mr. Schwarz holds an A.B. from Duke University where he was an Angier B. Duke Scholar, an M.B.A. from Harvard Business School, and a J.D. from Harvard Law School.

AcuFocus

Name

Charles Warden

Gregory Madden

James Garvey

Juliet Bakker

Ryan Schwarz

Firm

Work History

Charles Warden is a Managing Director who has been a medical device venture investor since 1992. He works closely with entrepreneurial device companies every step of the way, from inception to success. Prior to joining Versant he was a general partner at Schroder Ventures Life Sciences (now SV Life Sciences) where he led the SV medical device effort. Previously, Charles worked with Boston Capital Ventures, where he concentrated on medical device and other healthcare investments. Before becoming a venture capitalist, Charles was a consultant with Monitor Company, a strategy consulting firm. Charles has been actively involved with The Innovation Factory, a medical devices incubator, since its beginnings in 1999. He is also involved in ForSight Labs, an ophthalmic incubator, and with The Foundry, a medical devices incubator.

Ms. Bakker is a Managing Director and Founder of Longitude Capital. Prior to Longitude Capital, Ms. Bakker was a Managing Director of Pequot Ventures, where she founded the life sciences investment practice. Prior to Pequot, she was Director, Strategic Planning and Director, Operations of Waste Management International, and was a sell-side equity analyst with Banque Paribas. Ms. Bakker began her career as an investment banker in the corporate finance department at PaineWebber. She currently serves on the boards of Ceribell, Endogenex, Nalu, and RxSight (RXST). Selected prior board memberships include Ablation Frontiers (acquired by Medtronic), Alphaeon, AqueSys (acquired by Allergan), Axonics Modulation Technologies (AXNX), CryoVascular Systems (acquired by Boston Scientific), Eargo (EAR), Embolic Protection (acquired by Boston Scientific), Enteric Medical (acquired by Boston Scientific), eyeonics (acquired by Bausch+Lomb), Genyx Medical (acquired by C.R. Bard), Insulet (PODD), Precision Dermatology (acquired by Valeant Pharmaceuticals), Sadra Medical (acquired by Boston Scientific), and Venus Concept (VERO). Ms. Bakker holds an MPA from the Harvard Kennedy School and a BSc from the College of Agriculture and Life Sciences (”CALS”) at Cornell University, where she is a member of the CALS Advisory Council.

Mr. Schwarz has nearly 20 years of investment and financing experience in healthcare. Prior to co-founding NaviMed Capital, Mr. Schwarz led the US healthcare venture and growth capital practice at The Carlyle Group for 14 years. His team’s investing activities focused particularly on medical devices and products, healthcare information technology and selected healthcare services. He joined The Carlyle Group in 1997 at the inception of its $210 million initial US venture capital fund, and led the healthcare investing practice from that time through the venture group’s second fund, which closed on $602 million in 2001 targeting venture and growth capital investments, and third fund, which closed on $605 million in 2006 targeting growth capital investments and growth-oriented leveraged buyouts. Mr. Schwarz previously was a Vice President in the healthcare group at Robertson Stephens, where he led the firm’s healthcare IT investment banking efforts and also served clients in the medical device and healthcare services sectors. Earlier in his career, Mr. Schwarz was an investment banker at Morgan Stanley. Mr. Schwarz is currently a member of the Board of Directors of AcuFocus, AqueSys, NeoVista, and Proteus Digital Health. He was formerly a Director of numerous prior portfolio companies of The Carlyle Group, including Carefx (sold to Harris), ConnectiCare (sold to Emblem Health), Endius (sold to Zimmer), Fairchild Imaging (sold to BAE Systems), LipoSonix (sold to Medicis Pharmaceuticals) and Heritage Health Systems (sold to Universal American). Mr. Schwarz currently serves on the Board of George Mason Intellectual Properties (GMIP) which manages the commercialization of the university’s patents. He also serves as President of the Hungarian-American Enterprise Scholarship Fund, which provides fellowships to promising young Hungarian nationals to obtain private sector professional experience in the United States. From 2006 to 2011, Mr. Schwarz served on the Board of the Mid-Atlantic Venture Association, the industry association for venture capital and private equity firms in the Mid-Atlantic region. Mr. Schwarz holds an A.B. from Duke University where he was an Angier B. Duke Scholar, an M.B.A. from Harvard Business School, and a J.D. from Harvard Law School.

Other Seats

AcuFocus

AcuFocus

AcuFocus

AcuFocus

AcuFocus

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Compare AcuFocus to Competitors

Neoss Logo
Neoss

Neoss develops dental implant technology. It helps in reducing patient treatment time, optimizing inventory control, and superior outcomes for patients. It was founded in 2000 and is based in Zurich, Switzerland.

Spineology Logo
Spineology

Spineology provides anatomy-conserving spinal technologies for surgeons and their patients. Its surgical techniques conserve spinal bone, ligament, and muscle tissue, committed to increasing procedural efficiency, reducing surgical morbidity, and accelerating patient recovery. The company was founded in 1996 and is based in Saint Paul, Minnesota.

E
EyeTechCare

EyeTechCare is a company focused on the healthcare sector, specifically in the field of glaucoma treatment. The company offers non-invasive solutions for glaucoma patients, utilizing focused ultrasound technology to manage the condition. EyeTechCare primarily serves the healthcare industry, particularly those dealing with eye health and glaucoma treatment. It was founded in 2008 and is based in Rillieux-la-Pape, France.

N
NovaLign Orthopaedics

NovaLign Orthopaedics, formerly known as OsteoLign, is developing a minimally invasive solution for long bone fractures.

S
Simpirica Spine

Simpirica is developing a dynamic stabilization system designed to stabilize the spine in flexion and help patients return to more healthy, active lifestyles. The company's lead product, the LimiFlex Spinal Stabilization System, is typically used in conjunction with a surgical decompression for the treatment of lumbar spinal stenosis with or without degenerative spondylolisthesis.

D
Dental Implants

Dental Implant Technologies (DIT) is a San Antonio based dental technology company providing an end to end suite of integrated implant based restorative services and products for dental patients requiring the replacement of most or all of their teeth. In the United States alone this market includes 30M individuals or a served addressable market of $96B including $26B for DIT's products and services. It is based in Scottsdale, Arizona.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.